Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amyloid PET after mild Traumatic Brain Injury
NCT01871610Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Florbetapir, sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
Florbetapir
Beyond the preview
Go deeper on NCT01871610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01871610.